AI algorithm landscape assessment
The challenge
Our client wanted to identify companies and institutions developing AI algorithms to detect a rare disease.
Our solution
We provided a competitive analysis of AI algorithms for a rare disease. Analysis was from the medical perspective to assess the level of evidence that exists to support each algorithm. We identified institutions and companies developing AI algorithms for the rare disease and mapped the AI algorithms to the patient diagnostic journey. Lastly, we developed a framework to evaluate the level of evidence supporting the AI algorithms.
The results
Overall, we offered strategies for the client to consider regarding its own AI algorithm and competitive AI algorithms for a rare disease.
Jump to a slide with the slide dots.
CNS indication/ Endpoint prioritization
A biopharma client with an early clinical stage compound, showing efficacy across multiple neuropsychiatric conditions, wished to prioritize...
Read moreMedical Affairs omnichannel platform
A large biopharma client objective aimed to optimize its omnichannel (OC) approach for HCP and patient Medical Education...
Read moreRare respiratory claims data analysis
A top biopharma client wanted to understand diagnosis and treatment patterns for a rare respiratory disease only recently associated as a sequela....
Read more